Revolutionizing Microbiological Water Testing for Legionella pneumophila
Almost 50 years after its first identified outbreak in Philadelphia, Legionella pneumophila remains difficult to track. Traditional culture-based methods are slow and laborious, with results taking up to 14 days.
Diamidex has created a method for enumerating pathogenic waterborne Legionella pneumophila, giving results equivalent or better than the ISO 11731:2017 method — in just 48 hours. This webinar discusses MICA Advance® Legionella, a fast culture-based detection method for the enumeration of culturable Legionella pneumophila, as part of your water risk management programme.
Key Learning Objectives
- Examine the limitations of the traditional culture method
- Why Pasteurian culture is a game changer for Legionella testing
- The MICA Advance Legionella optimized workflow for enumerating Legionella pneumophila in just 48 hours
About Diamidex
Diamidex develops and markets fast culture-based solutions with automatic enumeration and reporting for laboratories across a variety of industries, delivering earlier results that are more replicable, cost-efficient and equivalent to the gold standard, with a lower carbon footprint.
Watch Now: Revolutionizing Microbiological Water Testing for Legionella pneumophila
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- December 17, 2024
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and you'll go straight to the recording — we'll also email you the link.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar